Lithium Americas Corp vs 22nd Century Group Inc — how do they compare? Lithium Americas Corp trades at $2.35 (market cap $850.38M), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Lithium Americas Corp is far larger — about 1367.9× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 8,804,637). Which is the better fit depends on your goals — on Pluang, investors hold Lithium Americas Corp for 27 Days and 22nd Century Group Inc for 32 Days on average.
| LAC | XXII | |
|---|---|---|
Market Cap | $850.38M | $621.67K |
Volume | 8,804,637 | 45,625 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $10.05 | $483.00 |
52-Week Low | $2.36 | $0.80 |
Typical Hold Time | 27 Days | 32 Days |
Enterprise Value | $1.19B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Lithium Americas (LAC) trades at $2.36, down 2.28% with bearish technical signals but positive analyst sentiment. The company shows negative profitability metrics with ROE at -9.56% and net income of -$122.09M for 2025, though it has beaten EPS estimates in recent quarters. Strong financing activity ($1.14B in 2025) supports Thacker Pass development, a key growth catalyst.
Investment outlook balances development potential against current losses. The consensus price target of $4.00 suggests 70% upside, but execution risks and lithium price volatility remain concerns. Construction progress at Thacker Pass could drive rerating, though the stock faces near-term pressure from negative cash flow and market skepticism.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →